On Monday, Alphatec Holdings hit an important technical milestone, with its Relative Strength (RS) Rating entering into the 90-plus percentile with an improvement to 93, up from 90 the day before.
How To Use Stock Charts To Stay Profitable And Protected
IBD's proprietary rating measures price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the market's biggest winners tend to have an RS Rating north of 80 at the beginning of a new climb.
Alphatec Holdings is building a cup without handle with a 12.79 entry. See if the stock can clear the breakout price in volume at least 40% above average.
The company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 22%.
Alphatec Holdings earns the No. 25 rank among its peers in the Medical-Products industry group. Penumbra, Boston Scientific and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
